HLA-DOBeta Polyclonal Antibody, 20ul Drug Development and Evaluation and alpha2C

and alpha2C

It is an important effector controlling blood pressure and volume in the cardiovascular system

Inhibition of myosin phosphatase leads to increased myosin phosphorylation and enhanced smooth muscle contraction

Diseases associated with BLZF1 include paraneoplastic cerebellar degeneration and lissencephaly

HLA-DOBeta Polyclonal Antibody, 20ul Drug Development and Evaluation and alpha2CHLA DOB belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DOA) and a beta chain (DOB), both anchored in the membrane. It is located in intracellular vesicles. DO suppresses peptide loading of MHC class II molecules by inhibiting HLA DM. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26 28